Global Risk Management
Define and maintain a global operational risk management framework aligned with company strategy and TechOps priorities
Identify, assess, and prioritize operational, technological, cyber, supply chain, geopolitical, environmental, and regulatory risks across the global network
Maintain a consolidated TechOps risk register, including risk ownership, mitigation actions, and residual risk
Provide risk insights to support network footprint decisions, capacity planning, and major investments
Business Continuity
Design, implement, and govern a global Business Continuity Management (BCM) program
Ensure Business Impact Analyses (BIA) are performed for critical TechOps processes and sites
Define and maintain Business Continuity Plans (BCP) and Disaster Recovery (DR) strategies in collaboration with Operations and IT
Governance
Establish global policies, standards, and guidelines for risk and business continuity management
Ensure alignment with internal governance, audit requirements, and external standards
Train and coach site and functional teams on risk awareness, BCM principles, and crisis readiness
Master’s degree in Engineering, Operations Management, or Business Administration related field with at least 8 years of experience in risk management, business continuity in the pharmaceutical industry.
Proven professional leadership in managing complex, cross-functional initiatives with significant financial and operational impact.
Proven experience in global, multi‑site TechOps, manufacturing, or complex operational networks.
Solid understanding of pharmaceutical processes, business operations, industry dynamics, and emerging market trends.
Proficiency in project management methodologies and tools, with a process-oriented and independent work style.
Experience in management consulting or strategic roles is a plus.
Strong facilitation, communication, and influencing skills.
As a global healthcare company, Fresenius Kabi is Committed to Life. The company’s products, technologies, and services are used for the therapy and care of critically and chronically ill patients. With over 41,000 employees and present in over 100 countries, Fresenius Kabi’s expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies.
In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients’ nutritional status. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is the global leader in supplying blood collection bags and devices, supporting blood banks and healthcare facilities worldwide. The company’s I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care.
Fresenius Kabi takes a holistic approach to healthcare and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. With the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of healthcare.
Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing healthcare solutions on a global scale.
User information & community guidelines: https://www.fresenius-kabi.com/social-media-terms-conditions
Imprint: www.fresenius-kabi.com/imprint
